Literature DB >> 12478635

Prenatal diagnosis and treatment of fetal long QT syndrome: a case report.

Ing-Kuang Chang1, Ming-Kwang Shyu, Chien-Nan Lee, Miau-Ling Kau, Yu-Hsueh Ko, Song-Nan Chow, Fon-Jou Hsieh.   

Abstract

We report a case of a fetus presenting with bradycardia, intermittent atrioventricular (AV) block, ventricular tachycardia (VT) and the signs of fetal congestive heart failure (ascites and scrotal hydrocele) during mid-gestation. Prenatal treatment with beta-adrenergic blocker (propranolol) and digitalis glycosides was prescribed because of suspicion of long QT syndrome occurring with fetal congestive heart failure. The male baby was born at 39 weeks of gestation and showed a prolonged QT interval (QTc = 492 ms) and frequent variable AV block or alternating left and right bundle branch block, depending on the atrial rate. Prenatal administration of lidocaine failed to correct the fetal VT. Conversely, propranolol decreased the attack frequency of fetal VT. Postnatal administration of the K(+) channel opener (nicorandil) successfully shortened the QT interval and improved the outcome. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12478635     DOI: 10.1002/pd.475

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  8 in total

1.  Antenatal presentation of congenital long QT syndrome: A prenatal diagnosis not to be missed.

Authors:  Alban-Elouen Baruteau; Jean-Marc Schleich
Journal:  Pediatr Cardiol       Date:  2008-07-26       Impact factor: 1.655

2.  Noninvasive Fetal Electrocardiography in the Diagnosis of Long QT Syndrome: A Case Series.

Authors:  Neeta Sethi; Kiyoe Funamoto; Catherine Ingbar; Paige Mass; Jeffrey Moak; Ronald Wakai; Janette Strasburger; Mary Donofrio; Ahsan Khandoker; Yoshitaka Kimura; Anita Krishnan
Journal:  Fetal Diagn Ther       Date:  2020-07-02       Impact factor: 2.587

3.  Nicorandil normalizes prolonged repolarisation in the first transgenic rabbit model with Long-QT syndrome 1 both in vitro and in vivo.

Authors:  Jürgen Biermann; Kezhong Wu; Katja E Odening; Stefan Asbach; Gideon Koren; Xuwen Peng; Manfred Zehender; Christoph Bode; Michael Brunner
Journal:  Eur J Pharmacol       Date:  2010-10-17       Impact factor: 4.432

4.  Prenatal diagnosis and management of fetal Long QT syndrome.

Authors:  Viktor Tomek; Jan Skovranek; Roman A Gebauer
Journal:  Pediatr Cardiol       Date:  2008-08-15       Impact factor: 1.655

Review 5.  Role of congenital long-QT syndrome in unexplained sudden infant death: proposal for an electrocardiographic screening in relatives.

Authors:  Alban-Elouen Baruteau; Julien Baruteau; Ryad Joomye; Raphael Martins; Frédéric Treguer; Remi Baruteau; Jean-Claude Daubert; Philippe Mabo; Michel Roussey
Journal:  Eur J Pediatr       Date:  2009-03-06       Impact factor: 3.183

Review 6.  Fetal long QT syndrome manifested as atrioventricular block and ventricular tachycardia: a case report and a review of the literature.

Authors:  Sanitra Anuwutnavin; Prapat Wanitpongpan; Paweena Chungsomprasong; Jarupim Soongswang; Nattinee Srisantiroj; Tuangsit Wataganara
Journal:  Pediatr Cardiol       Date:  2012-09-18       Impact factor: 1.655

Review 7.  Pharmacological approach to the treatment of long and short QT syndromes.

Authors:  Chinmay Patel; Charles Antzelevitch
Journal:  Pharmacol Ther       Date:  2008-04       Impact factor: 12.310

8.  Successful prenatal management of ventricular tachycardia and second-degree atrioventricular block in fetal long QT syndrome.

Authors:  Akira Miyake; Heima Sakaguchi; Aya Miyazaki; Takekazu Miyoshi; Takeshi Aiba; Isao Shiraishi
Journal:  HeartRhythm Case Rep       Date:  2016-09-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.